ADA Scientific Sessions 2026 Abstract

Prescribing Pattern of GLP-1 Receptor Agonists among People with Newly Diagnosed Type 2 Diabetes: A Retrospective Cohort Study

By Joyce Y-C. Lee, Ifigeneia Stathaki, Sunghyun Hwang, Haoran Zhang

Study in peoplePopulations

The paper

Joyce Y-C. Lee, Ifigeneia Stathaki, Sunghyun Hwang, Haoran Zhang

Irvine

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1680-P

doi.org/10.2337/db26-1680-p

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression